Soligenix
SNGX
#10569
Rank
ยฃ4.3 M
Marketcap
ยฃ0.29
Share price
0.57%
Change (1 day)
-79.28%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -ยฃ9.46 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ6.96 Million a decrease over its 2023 earnings that were of -ยฃ5.66 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ9.46 Million35.87%
2024 -ยฃ6.96 Million22.96%
2023 -ยฃ5.66 Million-45.74%
2022 -ยฃ10.43 Million11.88%
2021 -ยฃ9.33 Million-32.37%
2020 -ยฃ13.79 Million83.18%
2019 -ยฃ7.53 Million11.57%
2018 -ยฃ6.75 Million19.29%
2017 -ยฃ5.66 Million33%
2016 -ยฃ4.26 Million-19.7%
2015 -ยฃ5.3 Million5.16%
2014 -ยฃ5.04 Million
2010 -ยฃ5.69 Million26.12%
2009 -ยฃ4.51 Million75.1%
2008 -ยฃ2.58 Million-45.38%
2007 -ยฃ4.71 Million-22.84%
2006 -ยฃ6.11 Million66.15%
2005 -ยฃ3.68 Million-16.65%
2004 -ยฃ4.41 Million13.28%
2003 -ยฃ3.9 Million-11.88%
2002 -ยฃ4.42 Million-59.44%
2001 -ยฃ10.89 Million378.18%
2000 -ยฃ2.28 Million-38.53%
1999 -ยฃ3.71 Million-18.43%
1998 -ยฃ4.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.33 B-210,134.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ7.88 B-85,726.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ5.70 B-62,017.23%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-ยฃ13.52 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ31.09 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.69 B-18,460.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-ยฃ2.05 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.12 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA